Skip to main content

Table 4 Interventions and outcomes of included trials

From: Efficacy and safety of Si-Jun-Zi-Tang-based therapies for functional (non-ulcer) dyspepsia: a meta-analysis of randomized controlled trials

Study ID Intervention Duration/ follow up Outcome measures Adverse event
Trial group Control group
Hu (2001) [32] MSJZT Pantoprazole 4 weeks/ NM 1) Response rate
2) Gastric emptying
NM
Cao (2008) [33] MSJZT Pantoprazole 4 weeks/ NM Response rate NM
Li (2008) [34] SJZT Pantoprazole 4 weeks/ 2 months Response rate Control group: 8 cases with abdominal discomfort, bloating, diarrhea
Deng and Su (2010)a [31] MSJZT (High dose) Pantoprazole 4 weeks/ NM Response rate NM
Deng and Su (2010)b [31] MSJZT (low dose) Pantoprazole 4 weeks/ NM Response rate NM
Mu (2012) [35] SJZT + Domperidone + Omeprazole Domperidone + Omeprazole 4 weeks/ NM Response rate NO
Zhang (2013) [36] SJZT + Mosapride Citrate Mosapride Citrate 4 weeks/ 6 months 1) Response rate
2) Relapse rate
NM
Lv (2014) [37] MSJZT Placebo 4 weeks 1) Quality of life
2) Response rate
3) Gastric emptying
NO
Zhang (2014) [38] MSJZT Placebo 4 weeks/ NM 1) Quality of life
2) Response rate
NO
Lan and Yuan (2016) [39] MSJZT Pantoprazole 4 weeks/ NM Response rate NM
Liu et al. (2016) [40] MSJZT + Domperidone Domperidone 8 weeks/ NM Response rate NO
Li (2016) [41] MSJZT Domperidone 60 days/ 6 months 1) Response rate
2) Relapse rate
NM
  1. NM not mentioned
  2. a high dosage; b low dosage